View Article

Abstract

The second-most common reason for death encyclopedically and a significant issue for mortal health is cancer. The focus of the current review is to bandy cancer treatment and issues with anti-cancer specifics. Nearly all cell types can develop cancer, a veritably varied group of roughly 200 ails with at least one factor in common “unbridled cellular development” that results in aberrant cell proliferation. In solid excrescences, cancerous cells may remain localized or in situ at the position of the original lesion, or they may come locally progressed or metastatic to distant point. Ninety percent of all cancer- related losses are due to by metastasis. It's the primary determinant of whether malice is high- threat, taking aggressive treatment, or low- threat, curable by active surveillance, surgical junking, or adjuvant remedy. Recent advancements in computational medicine discovery methodologies have not only produced important perceptivity into the field of cancer remedy but have also had a significant and impact on the development of new anticancer specifics. Within the compass of this review, we delved implicit remedial targets for anti-cancer medicines.

Keywords

Anti-Cancer; Cancer Therapy; Drug Resistance; Herbal; Prevention; Safety

Introduction

Cancer is a class of conditions in which a group of cells display the traits of unbridled growth, irruption and occasionally me- testacies. These three nasty parcels of cancer separate them from benign excrescences, which are tone- limited, do n't foray or metastasize. utmost cancers form a excrescence but some, like leukemia, do n't. Cancer may affect people at all periods, indeed fetuses, but threat for the more common kinds tends to increase with age. Cancer causes about 13 of all deaths. The uses of shops as drug are as old as mortal civilization. About 60 of the anticancer medicines are deduced from factory sources, e.g., Taxol from Taxus brevifolia, camptothecin from Camptotheca acuminata etc. It's noted that the operation of cancer is still lagging before and there's an critical need to search new medicines for the forestallment and treatment of cancer. In this environment, the shops still hold the stopgap for the operation of cancer

How Cancer Develops 

Carcinogenesis or oncogenesis is the process by which normal cells transfigure into cancerous, or nasty, cells. Development of cancer is a complex process that, despite decades of exploration, we still do not fully understand. One of the most common explanations is that no single event directly leads to cancer being. According to multiple sources, a series of processes beget normal cells to change into nasty cells. Most healthy cells follow an internal timepiece, what's generally appertained to as the cell cycle, meaning they go through stages in life.  

        <a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250602183142-10.png" target="_blank">
            <img alt="Pathophysiology.png" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250602183142-10.png" width="150">
        </a>
Pathophysiology 

The pathophysiology of cancer involves several stages. The first stage is inauguration,  where a mutation occurs in a cell's DNA, leading to the activation of oncogenes( genes that promote cell growth) or the inactivation of excrescence suppressor genes( genes that inhibit cell growth). The alternate stage is creation, where the shifted cells are stimulated to divide and grow fleetly, forming a small cluster of abnormal cells. The third stage is progression, where the abnormal cells continue to divide and grow, forming a excrescence that can foray girding apkins and spread to other corridor of the body through the bloodstream or lymphatic system. 

1. Symptoms Of Cancer 

  • Change in bowel or bladder habits.  
  • A sore that does not heal  
  • Unusual bleeding or discharge  
  • Major headache  
  • Indigestion or difficulty in swallowing  
  • Unexplained weight loss  
  • Very heavy night sweats or fever  

2. Types Of Cancer 

  • Carcinoma 
  • Sarcoma 
  • Melanoma 
  • Lymphoma 
  • Leukemia 

2.1 Carcinoma 

Carcinoma is the most common type of cancer, counting for 80 to 90 of all cancer judgments . Melanoma forms in epithelial towel which is towel that lines your organs, internal galleries in your body and your skin. Melanoma appears as excrescences that may form on your skin or in your lungs, guts, prostate, colon, feathers, pancreas, etc. 

2.2 Sarcoma 

A sarcoma is a rare type of nasty( cancerous) excrescence that develops in bone and connective towel, similar as fat, muscle, blood vessels, jitters and the towel that surrounds bones and joints. Symptoms depend on the excrescence’s size and position. Treatments include surgery, radiation, chemotherapy, targeted remedy and immunotherapy. 

2.3 Melanoma 

Melanoma is a kind of skin cancer that starts in the melanocytes. Melanocytes are cells that make the color that gives skin its color. The color is called melanin. Melanoma generally starts on skin that is frequently exposed to the sun. This involves the skin on the arms, back, face and legs. Melanoma also can form in the eyes. Infrequently, it can be inside the body, similar as in the nose or throat.

2.4 Lymphoma 

Lymphoma is a cancer of the lymphatic system. The lymphatic system is part of the body's germ- fighting and disease-fighting immune system. Lymphoma begins when healthy cells in the lymphatic system change and grow out of control. The lymphatic system includes lymph nodes.  They are found throughout the body. Most lymph nodes are in the abdomen, groin, pelvis, chest, underarms and neck. 

2.5 Leukemia 

Leukemia starts when the DNA of a single cell in your bone marrow changes (mutates) and can’t develop and function normally. Leukemia cells often behave like abnormal white blood cells. Treatments for leukemia depend on the type of leukemia you have, your age and overall health, and if the leukemia has spread to other organs or tissues. 

3. Treatment 

1) Non-Pharmacological 

Non-pharmacological management of cancer can include a variety of interventions to hell with physical, psychological, and social symptoms: 

  1. Physical symptoms: Resting, sleeping, drinking liquids, oral care, exercise, massage, heat or ice packs, transcutaneous electrical nerve stimulation (TENS) 
  2. Psychological symptoms: Support, resting, exercise, cognitive-behavioral therapy (CBT), mindfulness-based stress reduction, imagery, hypnosis, biofeedback, distraction training, relaxation training  
  3. Social symptoms: Pomades for skin and nail changes, berets, scarves, and wigs for alopecia  

2) Pharmacological 

Pharmacological treatment for cancer involves the use of medications to kill cancer cells, slow treatments for cancer: 

2.1 Chemotherapy 

  • Alkylating agents: Damage DNA to prevent cancer cell growth (e.g., cyclophosphamide). 
  • Antimetabolites: Interfere with cancer cell metabolism (e.g., 5-fluorouracil). 
  • Antitumor antibiotics: Bind to DNA and interfere with cancer cell growth (e.g., doxorubicin). 
  • Topoisomerase inhibitors: Block enzymes that help cancer cells divide (e.g., etoposide). 
  • Mitotic inhibitors: Block cell division (e.g., paclitaxel). 

2.2 Targeted Therapies 

  • Monoclonal antibodies: Bind to specific proteins on cancer cells (e.g., rituximab). 
  • Tyrosine kinase inhibitors: Block enzymes that help cancer cells grow (e.g., imatinib). 
  • Angiogenesis inhibitors: Block the growth of new blood vessels that feed cancer cells (e.g., bevacizumab). 

2.3 Hormonal Therapies 

  • Estrogen receptor antagonists: Block estrogen receptors on breast cancer cells (e.g., tamoxifen). 
  • Aromatase inhibitors: Block the production of estrogen in postmenopausal women (e.g., anastrozole). 
  • Androgen deprivation therapy: Reduces testosterone levels to slow prostate cancer growth (e.g., leuprolide). 

2.4 Immunotherapies 

  • Checkpoint inhibitors: Release the brakes on the immune system to attack cancer cells (e.g., pembrolizumab). 
  • Cancer vaccines: Stimulate the immune system to recognize and attack cancer cells (e.g., sipuleucel-T). 
  • Adoptive T-cell therapy: Uses a patient's own immune cells to attack cancer cells.  

3. Anit Cancer  

  • Glucocorticods: Prednisolone  
  • Estrogens: Fosfestrol, ethinylestradiol  
  • Selective estrogen receptor modulators: Tamoxifen  
  • Selective estrogen receptor down-regulators: Fulvestrant  
  • Aromatase inhibitors: Letrozole, Anastrozole  
  • Antiandrogen: Flutamide  
  • 5-a reductase inhibitor: Finasteride  
  • GnRH analogues: Nafarelin, Triotorelin  
  • Progestins: Hydroxyprogesterone acetate  

4. Herbal Drugs Used to Treat Cancer 

1. Astragalus 

Biological Source- Chemical Constituents- 

  • Saponins: Astragalosides I-VII, astramembrannin I-III 
  • Flavonoids: Kaempferol, quercetin, isorhapontigenin 
  • Polysaccharides: Astragalus polysaccharides (APS) 
  • Amino acids: Asparagine, glutamine, arginine  5. Minerals: Calcium, iron, magnesium, potassium 

Family- 

  • Fabaceae (Leguminosae), a family of flowering plants commonly known as legumes. Dose-  
  • Traditional Chinese Medicine: 10-30 grams of dried root per day 
  • Dietary Supplement: 400-800 mg of standardized extract per day 
  • Clinical Trials: 2-4 grams of dried root per day 

        <a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250602183142-9.jpg" target="_blank">
            <img alt="Betula Utilis.jpg" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250602183142-9.jpg" width="150">
        </a>
2. Betula Utilis 

Biological Source-  

Betula utilis D. Don, also known as Himalayan Birch, is a deciduous tree native to the Himalayas. 

Chemical Constituents-  

  1. Triterpenoids: Betulinic acid, betulin, lupeol  
  2. Flavonoids: Quercetin, kaempferol, myricetin  
  3. Phenolic acids: Salicylic acid, gallic acid, ferulic acid  
  4. Volatile oils: Betulenol, betulol  

Family-  

Betulaceae, a family of deciduous trees and shrubs commonly known as birches. 

Dose-  

  • Traditional Ayurvedic Medicine: 1-2 grams of dried bark per day 
  • Dietary Supplement: 400-800 mg of standardized extract per day 3. Clinical Trials: 2-4 grams of dried bark per day 

<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250602183142-8.jpg" target="_blank"><img alt="4.jpg" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250602183142-8.jpg" width="150">
        </a>

3. Ginger 

Biological Source- 

Zingiber officinale Roscoe, a perennial plant native to Southeast Asia.

Chemical Constituents-  

  • Volatile oils: Gingerol, shogaol, zingiberene 
  • Phenolic compounds: Gingerone, paradol, gingerenone A 
  • Flavonoids: Quercetin, kaempferol, isorhapontigenin 
  • Saponins: Zingiber saponins 

Family-  

Zingiberaceae, a family of flowering plants commonly known as the ginger family. 

Dose- 

  • Traditional Ayurvedic Medicine: 250-500 mg of dried root per day 
  • Dietary Supplement: 250-1000 mg of standardized extract per day 
  • Clinical Trials: 500-2000 mg of dried root per day 

        <a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250602183142-7.jpg" target="_blank">
            <img alt="3. Ginger.jpg" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250602183142-7.jpg" width="150">
        </a>
4. Turmeric 

Biological Source-  

Curcuma longa L., a perennial plant native to India and Southeast Asia. 

Chemical Constituents-  

  • Curcuminoids: Curcumin, dimethoxy curcumin, bisdemethoxy curcumin  
  • Volatile oils: Turmerone, atlantone, zingiberene  
  • Flavonoids: Quercetin, kaempferol, isorhapontigenin  
  • Polysaccharides: Curculigoside, curcumanol  

Family-  

Zingiberaceae, a family of flowering plants commonly known as the ginger family. 

Dose-  

  • Traditional Ayurvedic Medicine: 1-2 teaspoons of turmeric powder per day 
  • Dietary Supplement: 500-2000 mg of curcuminoids per day 3. Clinical Trials: 1-4 grams of curcuminoids per day 

        <a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250602183142-6.jpg" target="_blank">
            <img alt="Biological Source-.jpg" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250602183142-6.jpg" width="150">
        </a>
5. ESSIAC Tea 

Biological Source- 

Essiac Tea is a blend of four herbs: 

  • Burdock root (Arctium lappa) 
  • Sheep's sorrel (Rumex acetosella) 
  • Slippery elm bark (Ulmus rubra) 
  • Indian rhubarb root (Rheum palmatum) 

Chemical Constituents- 

  • Burdock root: Inulin, lignans, flavonoids 
  • Sheep's sorrel: Anthraquinones, flavonoids, vitamins A and C 
  • Slippery elm bark: Mucilages, flavonoids, phenolic acids 
  • Indian rhubarb root: Anthraquinones, flavonoids, stilbenes 

Family- 

  • Burdock root: Asteraceae 
  • Sheep's sorrel: Polygonaceae 
  • Slippery elm bark: Ulmaceae 
  • Indian rhubarb root: Polygonaceae 

Dose- 

  • Traditional dose: 1-2 cups of tea per day 
  • Recommended dose: 1 cup of tea (2-4 grams of dried herbs) 2-3 times a day 

        <a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250602183142-5.jpg" target="_blank">
            <img alt="5. ESSIAC Tea.jpg" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250602183142-5.jpg" width="150">
        </a>
6. Burdock Root 

Biological Source- 

Arctium lappa L., a biennial plant native to Europe, Asia, and North America.

Chemical Constituents-  

  • Inulin: A polysaccharide that acts as a prebiotic 
  • Lignans: Arctigenin, arctiin, and matairesinol 
  • Flavonoids: Quercetin, kaempferol, and isorhapontigenin 
  • Volatile oils: Sesquiterpenes and phenylpropanoids 
  • Minerals: Potassium, calcium, and iron 

Family- 

Asteraceae (Compositae), a family of flowering plants commonly known as the daisy family. 

Dose- 

  • Traditional dose: 1-2 grams of dried root per day 
  • Recommended dose: 500-1000 mg of standardized extract per day 
  • Clinical trials: 1-3 grams of dried root per day 

        <a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250602183142-4.jpg" target="_blank">
            <img alt="Burdock Root.jpg" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250602183142-4.jpg" width="150">
        </a>
7. Hypercin 

Biological Source- 

Hypericum perforatum L., a perennial plant native to Europe, Asia, and North Africa.

Chemical Constituents-  

  • Hypericin: A naphthodianthrone derivative 
  • Hyperforin: A phloroglucinol derivative 
  • Flavonoids: Quercetin, kaempferol, and isorhapontigenin 
  • Volatile oils: Sesquiterpenes and phenylpropanoids 

Family- 

Hypericaceae, a family of flowering plants commonly known as the St. John's Wort family. 

Dose- 

  1. Traditional dose: 300-1000 mg of dried herb per day 
  2. Recommended dose: 300-900 mg of standardized extract per day 
  3. Clinical trials: 500-1800 mg of standardized extract per day 

        <a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250602183142-3.jpg" target="_blank">
            <img alt="7. Hypercin.jpg" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250602183142-3.jpg" width="150">
        </a>
8. Azadirachta Indica 

Biological Source-  

Azadirachta indica A. Juss, a deciduous tree native to the Indian subcontinent. 

Chemical Constituents- 

  • Azadirachtin: A tetranortriterpenoid insecticide 
  • Nimbin: A triterpenoid with anti-inflammatory and antipyretic properties 
  • Nimbidin: A triterpenoid with anti-inflammatory and antioxidant properties 4. Quercetin: A flavonoid with anti-inflammatory and antioxidant properties 

Family-  

Meliaceae, a family of flowering plants commonly known as the mahogany family. 

Dose- 

  • Traditional dose: 1-2 grams of dried leaf or bark per day 
  • Recommended dose: 500-1000 mg of standardized extract per day 
  • Clinical trials: 1-2 grams of dried leaf or bark per day 

        <a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250602183142-2.jpg" target="_blank">
            <img alt="8. Azadirachta Indica.jpg" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250602183142-2.jpg" width="150">
        </a>
9. Betula Alba 

Biological Source- 

Betula alba L., a deciduous tree native to Europe, Asia, and North Africa.

Chemical Constituents-  

  • Betulin: A triterpenoid with anti-inflammatory and antimicrobial properties 
  • Betulinic acid: A triterpenoid with anti-inflammatory and antiviral properties 
  • Flavonoids: Quercetin, kaempferol, and isorhapontigenin 
  • Volatile oils: Sesquiterpenes and phenylpropanoids 

Family-  

Betulaceae, a family of deciduous trees and shrubs commonly known as the birch family. 

Dose- 

  • Traditional dose: 1-2 grams of dried bark per day 
  • Recommended dose: 500-1000 mg of standardized extract per day 
  • Clinical trials: 1-2 grams of dried bark per day 

        <a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250602183142-1.jpg" target="_blank">
            <img alt="9. Betula Alba.jpg" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250602183142-1.jpg" width="150">
        </a>
1. Mangifera Indica 

Biological Source-  

Mangifera indica L., a deciduous tree native to South Asia. 

  • Chemical Constituents- 
  • Vitamins: Vitamin A, vitamin C, and vitamin E 
  • Minerals: Potassium, magnesium, and iron 
  • Flavonoids: Quercetin, kaempferol, and isorhapontigenin 
  • Phenolic acids: Gallic acid, ferulic acid, and cinnamic acid 
  • Terpenoids: Lupeol, mangiferin, and mangostin 

Family-  

Anacardiaceae, a family of flowering plants commonly known as the cashew family. 

Dose- 

  • Traditional dose: 1-2 grams of dried fruit per day 
  • Recommended dose: 500-1000 mg of standardized extract per day 
  • Clinical trials: 1-2 grams of dried fruit per day 

        <a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250602183142-0.jpg" target="_blank">
            <img alt="LAST.jpg" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250602183142-0.jpg" width="150">
        </a>
CONCLUSION: -  

In recent times, considerable attention has been concentrated on relating naturally being substances able of inhibiting, braking, or reversing the process of multistage carcinogenesis. Anticancer medicine having low side goods, converting apoptosis and target specific cytotoxicity to the cancer cells are medicines of choice.

REFERENCES

  1. Verma M, Singh SK, Bhushan S, Sharma VK, Datt P, et al., (2008) In vitro cytotoxic potential  of Polyalthia longifolia on human cancer cell lines and induction of apoptosis through mitochondrial-dependent pathway in HL-60 cells. Chem Biol Interact. 171(1): 45-56. 
  2. Shi M, Cai Q, Yao L, Mao Y, Ming Y, et al., (2006) Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells. Cell Biol Int. 30(3): 221-6. 
  3. Hartwell JL (1971) Plants used against cancer- A survey. Lloydia . 34(4): 204-55. 
  4. Newman DJ, Cragg GM, Snader KM (2003) Natural products as sources of new drugs over the period 1981-2002. J Nat Prod. 66(7): 1022-37. 
  5. Cragg GM, Schepartz SA, Suffness M, Grever MG (1993) The Taxol supply crisis. New NCI  policies for handling the large scale production of novel natural product anticancer and anti HIV agents. J Nat Prod. 56(10): 1657-68. 
  6. Hande KR (1998) Etopside: four decades of development of a topoisomerase II inhibitor.  Eur J Cancer. 34(10): 1514-21. 
  7. Chabner BA, Lango DL (2001) Topoisomerase II inhibitors: the epipodophyllotoxins, m–  AMSA and the ellipticine derivatives. Cancer Chemotherapy and Biotherapy: Principles and  Practice. 3rd (Edn), Lippincott Williams and Wilkins, Philadelphia. 
  8. Wani MC, Taylor WHC, Coggon ME, Phail MC (1971) Plant antitumor agents. The isolation  and structure of Taxol, a novel antileukemic and antitumor agent from Taxus brevifolia .J Am  Chem Soc. 93(9): 2325-7. 
  9. Schiff PB, Fant J, Horwitz SB (1979) Promotion of microtubule assembly in vitro by Taxol. Nature. 277(5698): 665-7. 
  10. Horwitz SB (2004) Personal recollections on the early development of Taxol. J Nat Prod. 
  11. Moudi M, Go R, Yien CSK, Nazre M (2013) Vinca Alkaloids. Int J Prev Med. 4(11): 1231–5. 
  12. Nahata A (2013) Ganoderma lucidum: A Potent Medicinal Mushroom with Numerous Health Benefits. Pharmaceut Anal Acta. 4: e159. 
  13. Gao JJ, Nakamura N, Min BS, Hirakawa A, Zuo F, et al., (2004) Quantitative determination of bitter principles in specimens of Ganoderma lucidum using high-performance liquid chromatography and its application to the evaluation of Ganoderma products. Chem Pharm Bull. 52(6): 688-95. 
  14. Nahata A, Saxena A, Suri N, Saxena AK, Dixit VK (2013) Sphaeranthus indicus induce  apoptosis through mitochondrial-dependent pathway in HL-60 cells and exerts cytotoxic potential on several human cancer cell lines. Integr Cancer Ther. 12(3): 23647. 
  15. Chi HJK, Amalini CJ, Karen SB, Marcus PG, Lynnette RF (2013) Anticancer activities of  Ganoderma lucidum: active ingredients and pathways. Funct Food Health Dis. 3(2): 48- 65.

Reference

  1. Verma M, Singh SK, Bhushan S, Sharma VK, Datt P, et al., (2008) In vitro cytotoxic potential  of Polyalthia longifolia on human cancer cell lines and induction of apoptosis through mitochondrial-dependent pathway in HL-60 cells. Chem Biol Interact. 171(1): 45-56. 
  2. Shi M, Cai Q, Yao L, Mao Y, Ming Y, et al., (2006) Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells. Cell Biol Int. 30(3): 221-6. 
  3. Hartwell JL (1971) Plants used against cancer- A survey. Lloydia . 34(4): 204-55. 
  4. Newman DJ, Cragg GM, Snader KM (2003) Natural products as sources of new drugs over the period 1981-2002. J Nat Prod. 66(7): 1022-37. 
  5. Cragg GM, Schepartz SA, Suffness M, Grever MG (1993) The Taxol supply crisis. New NCI  policies for handling the large scale production of novel natural product anticancer and anti HIV agents. J Nat Prod. 56(10): 1657-68. 
  6. Hande KR (1998) Etopside: four decades of development of a topoisomerase II inhibitor.  Eur J Cancer. 34(10): 1514-21. 
  7. Chabner BA, Lango DL (2001) Topoisomerase II inhibitors: the epipodophyllotoxins, m–  AMSA and the ellipticine derivatives. Cancer Chemotherapy and Biotherapy: Principles and  Practice. 3rd (Edn), Lippincott Williams and Wilkins, Philadelphia. 
  8. Wani MC, Taylor WHC, Coggon ME, Phail MC (1971) Plant antitumor agents. The isolation  and structure of Taxol, a novel antileukemic and antitumor agent from Taxus brevifolia .J Am  Chem Soc. 93(9): 2325-7. 
  9. Schiff PB, Fant J, Horwitz SB (1979) Promotion of microtubule assembly in vitro by Taxol. Nature. 277(5698): 665-7. 
  10. Horwitz SB (2004) Personal recollections on the early development of Taxol. J Nat Prod. 
  11. Moudi M, Go R, Yien CSK, Nazre M (2013) Vinca Alkaloids. Int J Prev Med. 4(11): 1231–5. 
  12. Nahata A (2013) Ganoderma lucidum: A Potent Medicinal Mushroom with Numerous Health Benefits. Pharmaceut Anal Acta. 4: e159. 
  13. Gao JJ, Nakamura N, Min BS, Hirakawa A, Zuo F, et al., (2004) Quantitative determination of bitter principles in specimens of Ganoderma lucidum using high-performance liquid chromatography and its application to the evaluation of Ganoderma products. Chem Pharm Bull. 52(6): 688-95. 
  14. Nahata A, Saxena A, Suri N, Saxena AK, Dixit VK (2013) Sphaeranthus indicus induce  apoptosis through mitochondrial-dependent pathway in HL-60 cells and exerts cytotoxic potential on several human cancer cell lines. Integr Cancer Ther. 12(3): 23647. 
  15. Chi HJK, Amalini CJ, Karen SB, Marcus PG, Lynnette RF (2013) Anticancer activities of  Ganoderma lucidum: active ingredients and pathways. Funct Food Health Dis. 3(2): 48- 65.

Photo
Kore Arundhati
Corresponding author

Navsahyadri Institute of Pharmacy Pune.

Photo
Jagruti Shelar
Co-author

Navsahyadri Institute of Pharmacy Pune.

Photo
Akanksha Shendkar
Co-author

Navsahyadri Institute of Pharmacy Pune.

Photo
Siddhi Nigade
Co-author

Navsahyadri Institute of Pharmacy Pune.

Arundhati Kore*, Jagruti Shelar, Akanksha Shendkar, Sidhi Nigde, TR VDCX Anticancer Agents: A Review of Relevant Information on Important Herbal Drugs, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 6, 235-246. https://doi.org/10.5281/zenodo.15576087

More related articles
Benzotriazole Derivatives And Its Pharmacological ...
Aniket Dandge, Shubhangi Manikpuriya, Gajanan Sanap, ...
Formulation Development And In Vitro Evaluation Of...
Shruti P. Gosavi, S. Z. Chemate, ...
Standardizing Herbal Cosmetics: Analytical Approac...
Dr. Sunayana Vikhe, Sakshi Kape, Rina Gaikwad, Mansi Jamdhade, ...
International Organization for Standardizations 9000 ...
Madhushri Mane, Rajlaxmi Patil, Pritee Mudagal, Amruta Nikam, Nita Sid, ...
The Impact Of Nanotechnology On Drug Delivery System...
Pranjal tukaram lahare, Shiddhesh sunil chavan, ...
Phytochemicals in Neurodegenerative Diseases: Natural Neuroprotectants ...
Sakshi Jatale, Rupali Chopade, Vedangi kulkarni, Shivani Chavan, Shatrughna Nagrik, Dr. Shivshankar ...
Related Articles
Development and Evaluation of Poly Herbal Orodispersible Films...
Sushmita K., Greeshma V., Akshmitha A., Hansika Reddy V., Rajeshwari P., Harshith B., Vineeth Nayak ...
Effect Of Sanctum on Cancer Progression and It’s Effective Therapeutic Activit...
Ashvini Dhurandar, Pranjal Salunke, Dr Gopalkrishna Sithaphle, Dr. Prafulla Tathe, ...
Cilnidipine And Risk Factors For Dementia Associated Parkinsonism – A Case Rep...
Dhanya Dharman, Silpa Siva Prasad, Anfi D. P, Shaiju S Dharan, ...
A Review on Green Chemistry and Catalysis...
Kanwate Chaitanya, Solunke Nandini, Pranita Waddar, Ashwini Dengle, Aditi Kamble, ...
Benzotriazole Derivatives And Its Pharmacological Activity...
Aniket Dandge, Shubhangi Manikpuriya, Gajanan Sanap, ...
More related articles
Benzotriazole Derivatives And Its Pharmacological Activity...
Aniket Dandge, Shubhangi Manikpuriya, Gajanan Sanap, ...
Standardizing Herbal Cosmetics: Analytical Approaches, Regulatory Complexities, ...
Dr. Sunayana Vikhe, Sakshi Kape, Rina Gaikwad, Mansi Jamdhade, ...